FDA Approves Pill Version of Wegovy
FDA Approves Pill Version of Wegovy
The US Food and Drug Administration (FDA) has approved a new pill version of Wegovy, a medication used to treat obesity. Novo Nordisk's semaglutide will soon be available in a daily pill Americans can take for weight loss.
According to WIRED, the FDA has approved the pill version of Wegovy, which will be available in a 25mg dose. The medication is designed to help people with obesity lose weight and improve their overall health.
The approval of the pill version of Wegovy is a significant development in the treatment of obesity. Obesity is a major public health concern, and the FDA has been working to approve new treatments for the condition.
The pill version of Wegovy is expected to be available in the coming months. Patients who are interested in taking the medication should speak with their healthcare provider to learn more about the treatment and to determine if it is right for them.